Skip to main content
. 2021 Jan 8;10:e60191. doi: 10.7554/eLife.60191

Figure 7. The MYC–host cell factor (HCF)–1 interaction is required for tumor engraftment and maintenance.

(A) Tumor engraftment schema: wild-type (WT), 4A-1, 4A-2, and ∆264 cells are switched in culture prior to injection into flank of nude mice to test the impact of the mutations on tumor engraftment and growth. (B) Average tumor volume over time following injection of switched cells. Shown are the mean and standard error for six mice each. Only days 5–19 are shown here; the full course of the experiment is depicted in Figure 7—figure supplement 1A. Student’s t-test between WT and each of the mutants was used to calculate p-value; *p<0.000043. (C) Kaplan–Meier survival curves of mice (n = 6 of each) injected with switched cells. Log-rank test was used to calculate p-value (<0.0001) from six biological replicates. (D) PCR assays of genomic DNA were used to determine the proportion of switched cells present in each tumor after sacrifice. Each dot represents an individual tumor, and the line indicates the mean for each group. Student’s t-test between WT and each of the mutants was used to calculate p-values; a = 0.0002, b < 0.0001. (E) Tumor maintenance schema: Unswitched WT, 4A-1, 4A-2, and ∆264 cells were injected into the flanks of nude mice. Tumors were grown until day 15, at which point mice received tamoxifen injections (one per day for 3 days) to induce switching of the cells. (F) Average tumor volume before and after cells were switched. The day at which tamoxifen (Tam) administration was initiated is indicated with an arrow. Shown are the mean and standard error for seven mice for WT and six mice for 4A-1, 4A-2, and ∆264 cells. (G) Kaplan–Meier survival curves of mice in the tumor maintenance assay (n = 7 for WT, and n = 6 for 4A-1, 4A-2, and ∆264). The day at which tamoxifen (Tam) administration was initiated is indicated with an arrow. Log-rank test was used to calculate p-value (<0.0001). (H) Annexin V staining and flow cytometry were performed on cells isolated from tumors at 48 and 96 hr following the first tamoxifen administration to determine the extent of apoptosis. Shown are the mean and standard error for four mice each. Student’s t-test between WT and each of the mutants was used to calculate p-value; *p<0.000001. (I) Venn diagram showing the relationship between transcripts significantly (false discovery rate [FDR] < 0.05) decreased in the 4A cell line and the 4A-1 and 4A-2 tumors. (J) Gene ontology (GO) enrichment analysis of transcripts significantly (FDR < 0.05) decreased in the 4A cell line and the 4A-1 and 4A-2 tumors. (K) Venn diagram showing the overlap of transcripts significantly (FDR < 0.05) increased in the 4A cell line and the 4A-1 and 4A-2 tumors. (L) GO enrichment analysis of transcripts significantly (FDR < 0.05) increased in the 4A cell line and the 4A-1 and 4A-2 tumors.

Figure 7—source data 1. Tumor volumes for engraftment and maintenance assays.
Figure 7—source data 2. Tumor RNA-Seq significant changes.

Figure 7.

Figure 7—figure supplement 1. Disruption of the MYC−host cell factor (HCF)–1 interaction in vivo.

Figure 7—figure supplement 1.

(A) Tumor volumes for individual mice in the tumor engraftment assay. (B) Tumor volumes for individual mice in the tumor maintenance assay. The day at which tamoxifen (Tam) administration was initiated is indicated with an arrow. (C) Caspase activity in cells isolated from tumors (n = 4 each) at 48 and 96 hr following the first tamoxifen administration was measured. Shown are the mean and standard error for the fold-change (FC) over wild type (WT) for each. Student’s t-test between WT and each of the mutants was used to calculate p-value; *p<0.000001. (D) Propidium staining and flow cytometry were performed on cells isolated from four tumors each at 48 and 96 hr following the first tamoxifen administration to determine the extent of cell death. Shown are the mean and standard error. Student’s t-test between WT and each of the mutants was used to calculate p-value; *p<0.000628, **p<0.000001. (E) z-transformed RNA-Seq data from tumors (n = 4) extracted after switching, ranked by FC. Transcripts that were significantly (false discovery rate [FDR] < 0.05) impacted compared to WT are shown. (F) Venn diagram showing the overlap of transcripts significantly (FDR < 0.05) decreased in the 4A-1, 4A-2, and ∆264 tumors. (G) Venn diagram showing the relationship of transcripts significantly (FDR < 0.05) increased in the 4A-1, 4A-2, and ∆264 tumors. (H) Gene ontology (GO) enrichment analysis of transcripts with significantly (FDR < 0.05) decreased expression in the 4A-1, 4A-2, and ∆264 tumors. (I) GO enrichment analysis of transcripts significantly (FDR < 0.05) increased in the 4A-1, 4A-2, and ∆264 tumors. (J) GO enrichment analysis of transcripts significantly (FDR < 0.05) decreased in vivo only (4A-1 and 4A-2 tumors, but not the 4A cell line). (K) GO enrichment analysis of transcripts significantly (FDR < 0.05) increased in vivo only (4A-1 and 4A-2 tumors, but not the 4A cell line).